Abnormal activation of NLRP3‐mediated pyroptosis has been linked to the progression of inflammatory bone loss disorders such as osteoporosis, periprosthetic osteolysis, rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Here, NLRP3 is linked to rheumatoid arthritis.